About Mounjaro

We Are The Best To Take Care Of You

Mounjaro (tirzepatide) is a prescription medicine developed by Eli Lilly. It is primarily used to improve blood sugar (glucose) control in adults with type 2 diabetes and is also being studied and prescribed off-label for weight loss. Mounjaro is a dual GIP and GLP-1 receptor agonist, which means it:

• Approved: Type 2 Diabetes (with diet & exercise)
• Off-label: Weight loss in non-diabetic individuals (under supervision)
• Helps reduce appetite
• Improves satiety (feeling of fullness)